Skip to content

Clinical trials

Observational Pulmonary Fibrosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Observational Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Chao Yang Hospital1
ChromX Health1
Creative Biosciences (Guangzhou) Co., Ltd.1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Kunming Medical University1
Ming Zhong1
Southeast University, China1
The First Affiliated Hospital with Nanjing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis8
Lung Neoplasms3
Bronchitis2
Emphysema2
Lung Diseases, Interstitial2
Pulmonary Disease, Chronic Obstructive2
Adenocarcinoma1
Asthma1
Bronchiectasis1
Bronchitis, Chronic1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.